Lars Håkan Olsson
Chairman at Belina Pharma AB
Profile
Lars Håkan Olsson is currently the Chairman of Belina Pharma AB, Belina AB, Director of Oncorena AB, Director of Hakmed AB, and Professor at Lund University Hospital.
He previously served as Director of Oncorena Holding AB and as an Independent Director at Odinwell AB from 2021 to 2022.
Lars Håkan Olsson active positions
| Companies | Position | Start |
|---|---|---|
| Lund University Hospital | Corporate Officer/Principal | - |
| Belina AB | Chairman | - |
Belina Pharma AB
 Belina Pharma AB Miscellaneous Commercial ServicesCommercial Services Belina Pharma AB researches, develops, markets, and trades drugs against breast cancer. The company is headquartered in Helsingborg, Sweden. | Chairman | - |
| Hakmed AB | Director/Board Member | - |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Director/Board Member | - |
Former positions of Lars Håkan Olsson
| Companies | Position | End |
|---|---|---|
| ODINWELL AB | Director/Board Member | 31/12/2021 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ODINWELL AB | Technology Services |
| Private companies | 6 |
|---|---|
| Lund University Hospital | |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Belina Pharma AB
Belina Pharma AB Miscellaneous Commercial ServicesCommercial Services Belina Pharma AB researches, develops, markets, and trades drugs against breast cancer. The company is headquartered in Helsingborg, Sweden. | Commercial Services |
| Belina AB | |
| Hakmed AB |
- Stock Market
- Insiders
- Lars Håkan Olsson
